5-54456158-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006308.3(HSPB3):​c.369T>C​(p.Gly123Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.61 in 1,613,514 control chromosomes in the GnomAD database, including 303,229 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 30948 hom., cov: 31)
Exomes 𝑓: 0.61 ( 272281 hom. )

Consequence

HSPB3
NM_006308.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.12

Publications

21 publications found
Variant links:
Genes affected
HSPB3 (HGNC:5248): (heat shock protein family B (small) member 3) This gene encodes a muscle-specific small heat shock protein. A mutation in this gene is the cause of autosomal dominant distal hereditary motor neuropathy type 2C.[provided by RefSeq, Sep 2010]
HSPB3 Gene-Disease associations (from GenCC):
  • distal hereditary motor neuropathy type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neuronopathy, distal hereditary motor, type 2C
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 5-54456158-T-C is Benign according to our data. Variant chr5-54456158-T-C is described in ClinVar as Benign. ClinVar VariationId is 353903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.12 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.727 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006308.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPB3
NM_006308.3
MANE Select
c.369T>Cp.Gly123Gly
synonymous
Exon 1 of 1NP_006299.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPB3
ENST00000302005.3
TSL:6 MANE Select
c.369T>Cp.Gly123Gly
synonymous
Exon 1 of 1ENSP00000303394.1

Frequencies

GnomAD3 genomes
AF:
0.631
AC:
95888
AN:
151888
Hom.:
30912
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.734
Gnomad AMI
AF:
0.718
Gnomad AMR
AF:
0.513
Gnomad ASJ
AF:
0.590
Gnomad EAS
AF:
0.358
Gnomad SAS
AF:
0.565
Gnomad FIN
AF:
0.627
Gnomad MID
AF:
0.677
Gnomad NFE
AF:
0.622
Gnomad OTH
AF:
0.631
GnomAD2 exomes
AF:
0.585
AC:
147027
AN:
251424
AF XY:
0.587
show subpopulations
Gnomad AFR exome
AF:
0.741
Gnomad AMR exome
AF:
0.479
Gnomad ASJ exome
AF:
0.597
Gnomad EAS exome
AF:
0.357
Gnomad FIN exome
AF:
0.626
Gnomad NFE exome
AF:
0.625
Gnomad OTH exome
AF:
0.611
GnomAD4 exome
AF:
0.607
AC:
887491
AN:
1461508
Hom.:
272281
Cov.:
49
AF XY:
0.606
AC XY:
440768
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.744
AC:
24920
AN:
33476
American (AMR)
AF:
0.480
AC:
21479
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.593
AC:
15499
AN:
26134
East Asian (EAS)
AF:
0.347
AC:
13784
AN:
39700
South Asian (SAS)
AF:
0.571
AC:
49259
AN:
86246
European-Finnish (FIN)
AF:
0.628
AC:
33557
AN:
53418
Middle Eastern (MID)
AF:
0.696
AC:
4012
AN:
5766
European-Non Finnish (NFE)
AF:
0.619
AC:
687966
AN:
1111654
Other (OTH)
AF:
0.613
AC:
37015
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
21566
43132
64697
86263
107829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18416
36832
55248
73664
92080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.631
AC:
95978
AN:
152006
Hom.:
30948
Cov.:
31
AF XY:
0.626
AC XY:
46473
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.734
AC:
30444
AN:
41462
American (AMR)
AF:
0.513
AC:
7831
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.590
AC:
2043
AN:
3462
East Asian (EAS)
AF:
0.358
AC:
1846
AN:
5154
South Asian (SAS)
AF:
0.565
AC:
2725
AN:
4820
European-Finnish (FIN)
AF:
0.627
AC:
6619
AN:
10564
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.622
AC:
42286
AN:
67962
Other (OTH)
AF:
0.634
AC:
1336
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1731
3462
5193
6924
8655
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.620
Hom.:
52323
Bravo
AF:
0.629
Asia WGS
AF:
0.481
AC:
1671
AN:
3478
EpiCase
AF:
0.625
EpiControl
AF:
0.631

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuronopathy, distal hereditary motor, type 2C Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:3
Nov 16, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
2.3
DANN
Benign
0.38
PhyloP100
-1.1
PromoterAI
-0.016
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7823; hg19: chr5-53751988; COSMIC: COSV57356586; API